We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 20th:
NeuBase Therapeutics, Inc. : This preclinical-stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 29.5% over the last 60 days.
Portage Biotech Inc. : This pharmaceutical and biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.
Nomad Foods Limited (NOMD - Free Report) : This frozen food company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4% over the last 60 days.
Image: Bigstock
Best Momentum Stocks to Buy for January 20th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 20th:
NeuBase Therapeutics, Inc. : This preclinical-stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 29.5% over the last 60 days.
NeuBase Therapeutics, Inc. Price and Consensus
NeuBase Therapeutics, Inc. price-consensus-chart | NeuBase Therapeutics, Inc. Quote
NeuBase’s shares gained 28.5% over the last one month compared with the S&P 500’s advance of 1.2%. The company possesses a Momentum Score of A.
NeuBase Therapeutics, Inc. Price
NeuBase Therapeutics, Inc. price | NeuBase Therapeutics, Inc. Quote
Portage Biotech Inc. : This pharmaceutical and biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.
Portage Biotech Inc. Price and Consensus
Portage Biotech Inc. price-consensus-chart | Portage Biotech Inc. Quote
Portage’s shares gained 1.8% over the last one month compared with the S&P 500’s advance of 1.2%. The company possesses a Momentum Score of B.
Portage Biotech Inc. Price
Portage Biotech Inc. price | Portage Biotech Inc. Quote
Nomad Foods Limited (NOMD - Free Report) : This frozen food company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4% over the last 60 days.
Nomad Foods Limited Price and Consensus
Nomad Foods Limited price-consensus-chart | Nomad Foods Limited Quote
Nomad’s shares gained 30.4% over the last three months compared with the S&P 500’s advance of 3.9%. The company possesses a Momentum Score of B.
Nomad Foods Limited Price
Nomad Foods Limited price | Nomad Foods Limited Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.